If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Find us on

UniverCité 2.0 : c’est (re)parti !

Après 6 mois de travaux, UniverCité, haut lieu de l’open innovation basé à Renens, prend de...

Challenge Debiopharm-Inartis : CHF 30 000 pour 6 projets innovants

Monsieur Thierry Mauvernay, co-président de Debiopharm Group a officiellement annoncé mardi 27 juin le nom...

Be Curious@UniverCité: le canal digital des entrepreneurs et innovateurs

Une bonne communication est un atout de poids pour les innovateurs de tous horizons. Afin...

Ambassadeur de la Health Valley, Sophia Genetics est une smart company

Une reconnaissance de plus pour Sophia Genetics qui prend la 30e place dans le classement...

Addex renforce son board

Roger Mills, médecin en chef d’Addex Therapeutics, basée à Campus Biotech – Genève, vient d’être...

Lonza/ Capsugel : les feux sont au vert

Le groupe Lonza a obtenu l’ensemble des feux verts nécessaires à la reprise du producteur...

Nestlé choie ses actionnaires

Ce n’est sûrement pas un hasard du calendrier. Deux jours après que le fonds Third...

Plus de pénicilline en Suisse

Un ratio bénéfice/ risque trop bas aura eu raison de la pénicilline en Suisse. Le...

Symetis : Medtech la plus innovante du Healthtech Summit 2017

Ambassadeur de la Health Valley, Symetis, portée par Jacques Essinger, vient de recevoir la plus...

Pourquoi la Suisse est, et reste au Top de l’innovation

Pourquoi la Suisse est, et reste au Top de l’innovation Pour la septième année consécutive,...

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator dedicated to life sciences located in the Canton of Vaud.

Merck KGaA, Darmstadt, Germany Licenses Selexis SUREtechnology Platform for Immuno-Oncology Antibody

Geneva, Switzerland, 30 MAY 2017 – Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that it has entered an agreement with an affiliate of Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, to leverage the Selexis SUREtechnology Platform™ and SURE CHO-M (suspension-adapted CHO-K1) cell line to advance a Merck KGaA, Darmstadt, Germany immuno-oncology antibody program.

Apidel SA announces R&D collaboration with DNDi in the field of neglected diseases

Apidel announces the signature of an agreement to collaborate with DNDi on the preclinical development of a topical treatment for Cutaneous Leishmaniasis, a neglected disease affecting between 0.7 to 1.2 million people worldwide. A promising drug candidate will be tested with Apidel’s proprietary drug delivery technology ApidSOL™.

Selexis SA and OSE Immunotherapeutics Sign Commercial License Agreement to Further Advance Developme

Selexis SA and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today the signing of a commercial license agreement that provides OSE Immunotherapeutics with access to high performance research cell banks (RCBs) from the Selexis SUREtechnology Platform™. The agreement builds upon previous collaboration between the two companies as announced in November 2016 and is designed to support the advancement of the clinical development of OSE’s interleukin receptor 7 antagonist, OSE-127 (Effi-7), under development as a potential treatment for inflammatory bowel diseases, such as ulcerative colitis.

Séance d’information du CAS/DAS/MAS en droit de la santé

Cette soirée d'information présente la formation continue en droit de la santé de l’Université de Neuchâtel, organisée en collaboration avec la Swiss School of Public Healthplus et l'Ecole romande de santé publique.

swissnex India's Medtech Road Show in Switzerland

Want to be part of the Indian 10 billion CHF Medtech market? Meet swissnex India's experts from June 12th to 16th in Zurich, Bern, Basel, Lausanne or Geneva.

Frontiers in Metabolism 2017–"From systems physiology to precision medicine”.

The symposium, co-organised by EPFL and EMBO Press, will be held from October 24 to October 26, 2017 (2.5 days) at the EPFL campus in Lausanne, Switzerland at the Swiss Tech Convention Center (STCC).
Archive:  2017  2016  2015  2014  2013  2012  2011  2010 
Find an actor

4à6 de BioAlps - Straumann15.06.2017

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

E-mail address